Should you pick Novavax ’s COVID-19 shot over mRNA options?
For cardiologist Eric Topol, this week’s vaccine news presented a personal dilemma. Topol, who directs the Scripps Research Translational Institute and is a popular commenter on COVID-19 research, had hoped to get an updated COVID-19 vaccine from Novavax, rather than a messenger RNA (mRNA) shot from Pfizer or Moderna. Novavax relies on an older, protein-based approach that has shown long-lasting effects against other pathogens, and Topol wondered whether it might produce more durable protection. On Tuesday, it seemed he might get his chance: a drugstore he visited for an mRNA vaccine ran out of doses, and hours later the...
Source: ScienceNOW - October 6, 2023 Category: Science Source Type: news
Immunity-enhancing cocktail protects mice against multiple hospital germs
Some people in hospital die not from the illness or accident that got them admitted but from germs they catch once there. In the United States alone, there are hundreds of thousands of hospital-acquired infections each year, leading to tens of thousands of deaths. Seeking to lower this toll, researchers have now come up with an
immune-boosting cocktail that increases the survival
of mice exposed to the microbes responsible.
The three-compound formulation, which the researchers unusually refer to as a vaccine, provided up to 28 days of protection from the notorious hospital bacterium
Pseudomonas aerugin...
Source: ScienceNOW - October 4, 2023 Category: Science Source Type: news
ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children - United States, 2023
This report describes an ACIP update recommending the use of the 20-valent pneumococcal conjugate vaccine in children. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 28, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
What a Doctor Is Seeing In COVID-19 Today
Hospitalizations for COVID-19 have been on the rise since the beginning of July. Then came the identification of the heavily mutated and possibly highly-transmissible BA.2.86 variant by the global surveillance network. Such a variant has the potential to evade our vaccine- and infection-induced antibodies and cause a surge of seasonal hospitalizations. The recommendation by the FDA’s VRBPAC in June that the Fall updated vaccine be composed of an XBB-lineage of the Omicron variant appeared to be at risk. There was mounting concern we be faced with a similar situation from last year where the virus had already mutated ...
Source: TIME: Health - September 25, 2023 Category: Consumer Health News Authors: Michael Daignault Tags: Uncategorized COVID-19 freelance Source Type: news
Pneumococcal Infection Reduced in Children With Sickle Cell Since PCV13
TUESDAY, Sept. 19, 2023 -- For children with sickle cell disease (SCD), the rates of invasive pneumococcal infection (IPD) have decreased since introduction of pneumococcal conjugate vaccines (PCVs), according to a study published online Sept. 12 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 19, 2023 Category: Pharmaceuticals Source Type: news
Too Many Mothers Are Dying in Childbirth. Here ’s How They Can Be Saved
With recent reports of difficult pregnancies and births from celebrities like Beyonce, Serena Williams, and Alyson Felix, and the death of Olympian Tori Bowie during childbirth, the long-overlooked dangers of maternal and child mortality have become increasingly prominent.
In a new report published by the Bill & Melinda Gates Foundation, the global health philanthropic group highlights lagging progress in achieving United Nations (UN) goals for lowering mother and child deaths, along with innovative ways of addressing the problems with relatively inexpensive and easy to implement solutions that the group projects co...
Source: TIME: Health - September 12, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Peninsula biotech grabs more space as it plans to take 2nd pneumonia vaccine into clinic
Vaxcyte and Codexis signed leases within weeks of each other in early 2021 at Alexandria Real Estate Equities' Alexandria District for Science& Technology in San Carlos. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 8, 2023 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Providers Have Inadequate Awareness of PCV20 Vaccination Recommendations
FRIDAY, Sept. 8, 2023 -- Two-thirds of health care providers agree or strongly agree with expanding recommendations for the new 20-valent pneumococcal conjugate vaccine (PCV20), according to research published in the Sept. 8 issue of the U.S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 8, 2023 Category: Pharmaceuticals Source Type: news
Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022
This report describes knowledge gaps and implementation challenges among health care providers in meeting pneumococcal vaccine recommendations. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 7, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Routine Vaccines Can Cut Risk for Later Alzheimer Disease
WEDNESDAY, Aug. 23, 2023 -- Prior vaccinations against tetanus and diphtheria, shingles, and pneumococcus are all associated with a reduced risk for developing Alzheimer disease, according to a study published online Aug. 7 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 23, 2023 Category: Pharmaceuticals Source Type: news
Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk
MONDAY, Aug. 21, 2023 -- Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer ' s disease, new research reveals.
Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 21, 2023 Category: General Medicine Source Type: news
Parents, Act Now: Pneumococcal Vaccines Protect Kids From Dangerous Diseases
Texas physicians have a message for parents getting ready to send their kids to daycare or school – make sure your children are up to date on their pneumococcal vaccine. The vaccine prevents infectious diseases that spread easily through a cough or sneeze in crowded settings. (Source: TMA News Room)
Source: TMA News Room - July 25, 2023 Category: Consumer Health News Source Type: news
The Head of the Global Vaccine Group Gavi Is Resigning. Here ’s What He Learned During the Pandemic
The COVID-19 pandemic was a crucible for the public health world, and perhaps none were tested more than Gavi, the global nonprofit that makes vaccines its business. Faced with ensuring that the COVID-19 vaccines reached as many people in the developing world as possible, the organization created a new entity, COVAX, that served as the conduit for purchasing and distributing vaccines for the lowest-resource countries in the world.
Dr. Seth Berkley, who has headed the organization for years, is stepping down in August when his current term ends.
In a conversation with TIME, Berkley reflects on his tenure and what he, Gavi, ...
Source: TIME: Health - July 24, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
The Head of the Global Vaccine Group Gavi Is Stepping Down. Here ’s What He Learned During the Pandemic
The COVID-19 pandemic was a crucible for the public health world, and perhaps none were tested more than Gavi, the global nonprofit that makes vaccines its business. Faced with ensuring that the COVID-19 vaccines reached as many people in the developing world as possible, the organization created a new entity, COVAX, that served as the conduit for purchasing and distributing vaccines for the lowest-resource countries in the world.
Dr. Seth Berkley, who has headed the organization for years, is stepping down in August when his current term ends.
In a conversation with TIME, Berkley reflects on his tenure and what he, Gavi, ...
Source: TIME: Health - July 24, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Is a ‘polyepidemic’ humanity’s next big threat? Childhood vaccine crusader shares concerns for future
By the start of 2011, the year epidemiologist Seth Berkley became CEO of Gavi, the Vaccine Alliance, the ambitious nonprofit had over its 11-year history supported the immunization of 288 million children in poor countries. But it also had a $3.7 billion funding gap between its plans and donor financial pledges. Making matters worse, an internal battle raged about how much it should invest in strengthening health systems versus more technological solutions, such as new or improved vaccines, favored by its main funder, the Bill & Melinda Gates Foundation. “It was a crisis,” Berkley says.
Berkley plans to step ...
Source: ScienceNOW - July 20, 2023 Category: Science Source Type: news
